Milford

Here's a round up of the latest real estate and development news from Central Massachusetts.

Veit Bergendahl previously led commissioning of his former firm’s R&D site and managed its single-use clinical manufacturing facility, featuring two 2,000-liter bioreactors. 

The closure comes seven months after Waters announced its acquisition plans in July.

Rentschler Biopharma, Germany-based biopharmaceuticals manufacturer with a U.S. headquarters in Milford, is undergoing a major executive transition as the firm’s CEO and chief operating officer have stepped down and an interim leader has been named.

Rentschler Biopharma, a Germany-based biopharmaceuticals manufacturer with a facility in Milford, is set to produce a novel blood coagulation treatment developed by Netherlands-based VarmX, with the hopes to support future commercialization.

With the incorporation, Milford Regional Physician Group brings its 135 physicians, 113 advanced practice providers, and 386 staff members to UMass Memorial Medical Group.

For the first time in four years, Milford Regional Healthcare Foundation’s Mélange 2025 Gala and Live Auction failed to raise at least $1 million, generating $560,000 less than it did last year.

A state auditor report has found the Mass Save program provides a skewed distribution of its resources...

Central Massachusetts professionals are being hired at organizations including bankHometown, Consigli Construction, and Cornerstone Bank.

The building is 76% occupied with 12 tenants, including Milford Regional Medical Center, Metrowest Oral Surgery, and Asthma & Allergy Physicians.